about
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancerVaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic miceGlioma stem cells and immunotherapy for the treatment of malignant gliomas.News on microenvironmental physioxia to revisit skin cell targeting approaches.MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.Therapeutic vaccination targeting the tumour vasculature.Development of Antibody-Based Vaccines Targeting the Tumor Vasculature.Fusion with human lung cancer cells elongates the life span of human umbilical endothelial cells and enhances the anti-tumor immunity.Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models.Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1.Robo4 vaccines induce antibodies that retard tumor growth.Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs.Evaluation of a xenogeneic vascular endothelial growth factor-2 vaccine in two preclinical metastatic tumor models in mice.Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors.
P2860
Q34385537-1C21D6EF-1570-4235-B679-B72F664EB4EFQ35068030-9EA29A15-71AD-480B-98DA-B2840DB938F3Q35740182-186F66F4-8334-4610-B85A-885E29AB7811Q36898699-BC5A942E-43ED-409D-B7FE-69D215C0FC62Q38033656-84FB5949-643B-41A9-84BE-C6C3F5694CF1Q38098095-EE53D830-70EE-4F4E-B89E-3411C87D7EC8Q38268464-32C4C5B7-2669-4D66-9CEC-042FD4E8B67BQ38778397-7B0EEE45-1EE3-41D9-A0F2-8B78616F1AAFQ38857075-DED00DE3-31BC-4C54-8436-6365852F9A64Q39165919-1D173AA9-07CB-4459-9179-1B893372FB4CQ39365796-C7A91BDF-DD54-4B9A-9C11-0DD9792B6FB7Q40829702-4944A1C9-84D9-41EB-BE2D-08DEB5CE7366Q41687753-F890EDC9-CDB0-4E13-9067-6BB28EBE198DQ42576477-DFE1CD3A-2123-4BDF-97AF-34F9AF508C44Q45870426-E884D07A-1310-47CA-98A1-1B424E0982B2Q51800441-915969D5-1951-4542-A241-7DD4E6EB1BE2Q54480921-93B7B316-C27A-4DC6-BFA9-56FD07679FFAQ54485562-C689CD66-EA7C-45B3-B517-826F366C41F4
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vaccines targeting the neovasculature of tumors
@ast
Vaccines targeting the neovasculature of tumors
@en
Vaccines targeting the neovasculature of tumors
@nl
type
label
Vaccines targeting the neovasculature of tumors
@ast
Vaccines targeting the neovasculature of tumors
@en
Vaccines targeting the neovasculature of tumors
@nl
prefLabel
Vaccines targeting the neovasculature of tumors
@ast
Vaccines targeting the neovasculature of tumors
@en
Vaccines targeting the neovasculature of tumors
@nl
P2093
P2860
P356
P1433
P1476
Vaccines targeting the neovasculature of tumors
@en
P2093
Archibald J Mixson
Qixin Leng
Szu-Ting Chou
P2860
P2888
P356
10.1186/2045-824X-3-7
P577
2011-03-08T00:00:00Z
P6179
1039115185